In experimental models of pathological conditions, such as ischemic stroke, claudin-1 is lost in the cerebral vasculature (49), claudin-5 expression is reduced (104, 105), and the interaction between claudin-5 and occludins is disrupted (106). Here, CLDN5 is linked to ischemic stroke.